Effects of cerulenin upon the syntheses of lipid and protein and upon the formation of respiratory enzymes in adapting, lipid-limited Saccharomyces cerevisiae.
When bakers' yeast cells were grown anaerobically in a medium supplemented with Tween 80 and ergosterol, exposure during aeration to the fatty acid synthesis inhibitor, cerulenin, had little effect upon respiratory adaptation, the induction of enzymes of electron transport, or the in vivo incorporation of [(14)C]leucine into mitochondrial membranes. These lipid-supplemented cells were apparently able to undergo normal respiratory adaptation utilizing endogenous lipids alone. The level of cerulenin used (2 mug/ml) inhibited the in vivo incorporation of [(14)C]acetate into mitochondrial membrane lipids by 96%. If, however, the cells were deprived of exogenous lipid during anaerobic growth, subsequent exposure to cerulenin severely reduced their capacity to undergo respiratory adaptation, to form enzymes of electron transport, and to incorporate amino acid into both total cell and mitochondrial membrane proteins. This cerulenin-mediated inhibition of enzyme formation and of protein synthesis was nearly completely reversed by the addition of exogenous lipid during the aeration of the cells. In lipid-limited cells, chloramphenicol also had dramatic inhibitory effects, both alone (75%) and together with cerulenin (85%), upon total cell and mitochondrial membrane [(14)C]leucine incorporation. This marked chloramphenicol-mediated inhibition was also largely reversed by exogenous lipid. It is concluded that, in lipid-limited cells, either cerulenin or chloramphenicol may prevent the emergence of a pattern of lipids required for normal levels of protein synthetic activity. The effect of cerulenin upon the formation of mitochondrial inner membrane enzymes thus appears to reflect a nonspecific effect of this antilipogenic antibiotic upon total cell protein synthesis.
D000935:Antifungal Agents / Q000494:pharmacology*; D002569:Cerulenin / Q000494:pharmacology*; D002701:Chloramphenicol / Q000494:pharmacology; D003579:Cytochrome Reductases / Q000096:biosynthesis; D003576:Electron Transport Complex IV / Q000096:biosynthesis; D005656:Fungal Proteins / Q000096:biosynthesis*; D008055:Lipids / Q000096:biosynthesis*; D008565:Membrane Proteins / Q000096:biosynthesis; D010088:Oxidoreductases / Q000096:biosynthesis*; D012441:Saccharomyces cerevisiae / Q000187:drug effects* / Q000378:metabolism
D000935:Antifungal Agents; D005656:Fungal Proteins; D008055:Lipids; D008565:Membrane Proteins; D002569:Cerulenin; D002701:Chloramphenicol; D010088:Oxidoreductases; D003579:Cytochrome Reductases; D003576:Electron Transport Complex IV